Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA
Titel:
Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA
Auteur:
Remon, J. Caramella, C. Jovelet, C. Lacroix, L. Lawson, A. Smalley, S. Howarth, K. Gale, D. Green, E. Plagnol, V. Rosenfeld, N. Planchard, D. Bluthgen, M.V. Gazzah, A. Pannet, C. Nicotra, C. Auclin, E. Soria, J.C. Besse, B.